Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple resistance training may ease RA muscle weakness

NCT ID NCT07487779

Symptom relief Sponsor: Kufa University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a structured progressive resistance training program can improve muscle strength in adults with rheumatoid arthritis (RA). About 118 participants will either do supervised exercises 3 times a week for 6 weeks or continue their usual care. Researchers will measure changes in muscle strength, heart function, and energy levels to see if the program helps with daily activities.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Progressive Resistance Training (exercise program)
What this could lead to
If it works, this could offer a safe, drug-free way to improve muscle strength and daily function for people with rheumatoid arthritis.
What could go wrong
This is a small, early-stage study with only 118 participants. The exercise program is short (6 weeks), so long-term benefits are unknown. Results may not apply to all RA patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 118 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with Rheumatoid Arthritis according to American College of Rheumatology criteria * Age 18-65 years * Both genders eligible * Disease duration of at least 6 months * Stable medication regimen for at least 3 months before study * Mild to moderate disease activity * Able to walk independently with or without assistive devices * Willing and able to provide informed consent * Agree to participate in the exercise program for 6 weeks * Attending AL-Najaf Teaching Hospital for RA management Exclusion Criteria: * Severe cardiovascular disease (unstable angina, recent MI, severe heart failure) * Other inflammatory arthritis (psoriatic arthritis, ankylosing spondylitis, lupus)- * Recent joint surgery or fracture within the past 6 months * Severe osteoporosis with fracture risk * Pregnancy * Severe cognitive impairment preventing participation * Uncontrolled hypertension (BP \>180/110 mmHg) * Active infection or fever at baseline * Severe joint damage preventing exercise participation * Participation in another exercise program during the study period * Neuromuscular disorders affecting muscle function

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rheumatoid arthritis (RA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rheumatoid arthritis (RA)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.